Literature DB >> 9368195

Brain glucose metabolism in borderline personality disorder.

J M De La Fuente1, S Goldman, E Stanus, C Vizuete, I Morlán, J Bobes, J Mendlewicz.   

Abstract

We searched for regional cerebral metabolic disturbances in patients with borderline personality disorder (BPD). Ten inpatients with BPD, no current DSM-IIIR Axis I diagnosis and free of any psychotropic substances, were compared with 15 age-matched control subjects using positron emission tomography with 2-deoxy-2-[18F]fluoro-D-glucose and semiquantitative analysis of regional glucose metabolic activity. We found relative hypometabolism in patients with borderline personality disorder at the level of the premotor and prefrontal cortical areas, the anterior part of the cingulate cortex and the thalamic, caudate and lenticular nuclei. This study shows significant cerebral metabolic disturbances in patients with borderline personality disorder. These metabolic disturbances, which are similar to some of those described in other psychiatric entities, may help to understand the characteristic clinical aspects of this disorder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368195     DOI: 10.1016/s0022-3956(97)00001-0

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  24 in total

1.  Impulsivity, aggression and brain structure in high and low lethality suicide attempters with borderline personality disorder.

Authors:  Paul Soloff; Richard White; Vaibhav A Diwadkar
Journal:  Psychiatry Res       Date:  2014-02-18       Impact factor: 3.222

Review 2.  Neuroimaging in borderline personality disorder.

Authors:  Christian Schmahl; J Douglas Bremner
Journal:  J Psychiatr Res       Date:  2005-10-18       Impact factor: 4.791

3.  Enhanced emotion-induced amnesia in borderline personality disorder.

Authors:  René Hurlemann; Barbara Hawellek; Wolfgang Maier; Raymond J Dolan
Journal:  Psychol Med       Date:  2007-01-16       Impact factor: 7.723

4.  An exploratory study of the relationship of symptom domains and diagnostic severity to PET scan imaging in borderline personality disorder.

Authors:  S Charles Schulz; Jazmin Camchong; Ann Romine; Amanda Schlesinger; Michael Kuskowski; Jose V Pardo; Kathryn R Cullen; Kelvin O Lim
Journal:  Psychiatry Res       Date:  2013-09-03       Impact factor: 3.222

5.  Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder.

Authors:  Paul H Soloff; Laurel Chiappetta; Neale Scott Mason; Carl Becker; Julie C Price
Journal:  Psychiatry Res       Date:  2014-03-29       Impact factor: 3.222

6.  Dysregulation of regional endogenous opioid function in borderline personality disorder.

Authors:  Alan R Prossin; Tiffany M Love; Robert A Koeppe; Jon-Kar Zubieta; Kenneth R Silk
Journal:  Am J Psychiatry       Date:  2010-05-03       Impact factor: 18.112

7.  Striatal activity in borderline personality disorder with comorbid intermittent explosive disorder: sex differences.

Authors:  M Mercedes Perez-Rodriguez; Erin A Hazlett; Erin L Rich; Luis H Ripoll; Daniel M Weiner; Nicole Spence; Marianne Goodman; Harold W Koenigsberg; Larry J Siever; Antonia S New
Journal:  J Psychiatr Res       Date:  2012-03-29       Impact factor: 4.791

Review 8.  Neuroimaging and genetics of borderline personality disorder: a review.

Authors:  Eric Lis; Brian Greenfield; Melissa Henry; Jean Marc Guilé; Geoffrey Dougherty
Journal:  J Psychiatry Neurosci       Date:  2007-05       Impact factor: 6.186

9.  Neural correlates of emotion processing in borderline personality disorder.

Authors:  Harold W Koenigsberg; Larry J Siever; Hedok Lee; Scott Pizzarello; Antonia S New; Marianne Goodman; Hu Cheng; Janine Flory; Isak Prohovnik
Journal:  Psychiatry Res       Date:  2009-04-24       Impact factor: 3.222

10.  Response inhibition in borderline personality disorder: event-related potentials in a Go/Nogo task.

Authors:  M Ruchsow; G Groen; M Kiefer; A Buchheim; H Walter; P Martius; M Reiter; L Hermle; M Spitzer; D Ebert; M Falkenstein
Journal:  J Neural Transm (Vienna)       Date:  2007-09-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.